Authors:
BLEIBERG H
CONROY T
PAILLOT B
LACAVE AJ
BLIJHAM G
JACOB JH
BEDENNE L
NAMER M
DEBESI P
GAY F
COLLETTE L
SAHMOUD T
Citation: H. Bleiberg et al., RANDOMIZED PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL (5-FU) VERSUS CISPLATIN ALONE IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER, European journal of cancer, 33(8), 1997, pp. 1216-1220
Citation: Es. Malicky et al., ENDOMETRIAL CARCINOMA PRESENTING WITH AN ISOLATED OSSEOUS METASTASIS - A CASE-REPORT AND REVIEW OF THE LITERATURE, European journal of gynaecological oncology, 18(6), 1997, pp. 492-494
Citation: Rpe. Vandookum et al., GENETIC-CONTROL OF SUSCEPTIBILITY TO GLOMERULAR DAMAGE IN RATS WITH L-NAME-INDUCED HYPERTENSION, Kidney international, 52(2), 1997, pp. 566-566
Authors:
CONROY T
ETIENNE PL
ADENIS A
WAGENER DJT
PAILLOT B
FRANCOIS E
BEDENNE L
JACOB JH
SEITZ JF
BLEIBERG H
VANPOTTELSBERGHE C
VANGLABBEKE M
DELGADO FM
MERLE S
WILS J
Citation: T. Conroy et al., PHASE-II TRIAL OF VINORELBINE IN METASTATIC SQUAMOUS-CELL ESOPHAGEAL-CARCINOMA, Journal of clinical oncology, 14(1), 1996, pp. 164-170
Authors:
MANDARD AM
DALIBARD F
MANDARD JC
MARNAY J
HENRYAMAR M
PETIOT JF
ROUSSEL A
JACOB JH
SEGOL P
SAMAMA G
OLLIVIER JM
BONVALOT S
GIGNOUX M
Citation: Am. Mandard et al., PATHOLOGICAL ASSESSMENT OF TUMOR-REGRESSION AFTER PREOPERATIVE CHEMORADIOTHERAPY OF ESOPHAGEAL-CARCINOMA, Cancer, 73(11), 1994, pp. 2680-2686